CellaVision AB (publ)
CEVI
Rank in Stocks
#12229
CellaVision AB (publ), a Swedish enterprise established in 1994 and based in... CellaVision AB (publ), a Swedish enterprise established in 1994 and based in Lund, specializes in crafting and distributing advanced digital systems for analyzing blood and other bodily fluids within the healthcare industry. The company serves a global market, with operations extending across Sweden, the wider European continent, the Middle East, Africa, the Americas, and the Asia Pacific region. Their core product line includes automated digital imaging devices such as the CellaVision DM1200 and DM9600, engineered to automatically capture detailed digital images of cells from blood smears and fluid preparations. Additionally, they offer the CellaVision DC-1 analyzer. Beyond hardware, CellaVision provides a suite of specialized software applications. The CellaVision Peripheral Blood Application streamlines and standardizes the morphological assessment of peripheral blood smears, while the CellaVision Advanced RBC Application facilitates a thorough examination of red blood cell morphology. For other body fluids, the CellaVision Body Fluid Application automates and standardizes their morphological evaluation. To enhance operational flexibility, the CellaVision Remote Review Software allows for the review of digital smears without geographical restrictions. Furthermore, the company delivers tools designed for laboratory management and educational purposes. The CellaVision Server Software integrates workflows across single or multiple testing facilities into a cohesive system. The CellaVision Dashboard provides an instant, visual summary of analyzer and reviewer performance data. The cloud-based CellaVision Proficiency Software assists laboratory managers in evaluating, tracking, and developing staff competency in cell morphology. For training and reference, the CellaVision CellAtlas features concise educational modules alongside a comprehensive cell image library. CellaVision also caters to the animal health sector with CellaVision VET, offering digital microscopy solutions for veterinary hematology. These innovative solutions are primarily supplied to hospitals and commercial laboratories worldwide.
Share Price
$20.41
Last synced: 2026-11-09
Market Cap
$486.70M
Change (1 day)
1.43%
Change (1 year)
20.18%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CellaVision AB (publ) (CEVI)
Category
Healthcare
Operating Margin for CellaVision AB (publ) (CEVI)
Operating Margin as of November 2026 TTM: 22.97%
According to CellaVision AB (publ)'s latest financial reports, its current operating margin (TTM) is 22.97%. At the end of 2025 the company had an operating margin of 26.62%.
Operating Margin history for CellaVision AB (publ) from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 22.97% | -13.71% |
| 2025 | 26.62% | 8.34% |
| 2024 | 24.57% | -0.36% |
| 2023 | 24.66% | -0.36% |
| 2022 | 24.75% | -13.97% |
| 2021 | 28.77% | 23.00% |
| 2020 | 23.39% | -14.67% |
| 2019 | 27.41% | -10.40% |
| 2018 | 30.59% | 4.08% |
| 2017 | 29.39% | 5.04% |
| 2016 | 27.98% | 2.30% |
| 2015 | 27.35% | 38.55% |
| 2014 | 19.74% | 36.80% |
| 2013 | 14.43% | 18.18% |
| 2012 | 12.21% | 6.64% |
| 2011 | 11.45% | 8.02% |
| 2010 | 10.60% | -21.83% |
| 2009 | 13.56% | 1.80% |
| 2008 | 13.32% | 216.39% |
| 2007 | 4.21% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -99.34% |
US
|
|
| 18.08% | -99.21% |
IE
|
|
| 21.25% | -99.07% |
US
|
|
| 21.05% | -99.08% |
US
|
|
| 28.09% | -98.78% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CellaVision AB (publ)'s operating margin
What is CellaVision AB (publ)'s operating margin?
CellaVision AB (publ)'s operating margin is 22.97%, as of Nov 2026.
What was CellaVision AB (publ)'s operating margin in 2025?
In 2025, CellaVision AB (publ)'s operating margin was 26.62%, compared with 24.57% in 2024.
How has CellaVision AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, CellaVision AB (publ)'s operating margin was highest in 2021 (28.77%) and lowest in 2020 (23.39%).
How does CellaVision AB (publ)'s operating margin compare with similar companies?
CellaVision AB (publ)'s operating margin (22.97%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.